Filing Flows › Insmed (INSM) › Recalls, complaints & regulation
Insmed (INSM): clinical trials
Insmed (INSM) beyond its filings: 10 active clinical trials.
Insmed's latest quarter
Insmed, Q3 2026: revenue $524M (+268% year over year), operating margin -17.0%, net loss $100M, operating cash flow −$36.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Insmed have?
10 active studies on ClinicalTrials.gov, 5 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.